Literature DB >> 20133526

FDA approves tocilizumab to treat rheumatoid arthritis.

Cheryl A Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133526     DOI: 10.2146/news100012

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

1.  Interleukin-6 modulates graft-versus-host responses after experimental allogeneic bone marrow transplantation.

Authors:  Isao Tawara; Motoko Koyama; Chen Liu; Tomomi Toubai; Dafydd Thomas; Rebecca Evers; Peter Chockley; Evelyn Nieves; Yaping Sun; Kathleen P Lowler; Chelsea Malter; Norihiro Nishimoto; Geoffrey R Hill; Pavan Reddy
Journal:  Clin Cancer Res       Date:  2010-11-03       Impact factor: 12.531

Review 2.  IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment.

Authors:  Sara G Manore; Daniel L Doheny; Grace L Wong; Hui-Wen Lo
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 5.738

Review 3.  The paradox of cancer genes in non-malignant conditions: implications for precision medicine.

Authors:  Jacob J Adashek; Shumei Kato; Scott M Lippman; Razelle Kurzrock
Journal:  Genome Med       Date:  2020-02-17       Impact factor: 11.117

4.  Anti-Interleukin-6 Promotes Allogeneic Bone Marrow Engraftment and Prolonged Graft Survival in an Irradiation-Free Murine Transplant Model.

Authors:  Nicolas Granofszky; Andreas M Farkas; Moritz Muckenhuber; Benedikt Mahr; Lukas Unger; Svenja Maschke; Nina Pilat; Raimund Holly; Mario Wiletel; Heinz Regele; Thomas Wekerle
Journal:  Front Immunol       Date:  2017-07-19       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.